4
Changes in Ownership
KYNTRA BIO, INC. Filed Acc 0001209191-21-015010
SVP, Clinical Dev, Drug Safety acquired 20,800 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kouchakji Elias SVP, Clinical Dev, Drug Safety | 2021-02-24 | Grant or award | +20,800 | 152,567 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Kouchakji Elias SVP, Clinical Dev, Drug Safety | 2021-02-24 | Grant or award · Stock Option (Right to Buy) | +39,900 | 39,900 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…